Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

Current automatic metrics for long-form question answering don't align with human preferences; a multi-faceted evaluation approach is needed.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

There is a significant need for better-validated quality of life tools in dermatology.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

The questionnaire is valid and reliable but needs more testing for future predictions.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Disease-specific tools better assess alopecia areata's impact on quality of life.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Alopecia areata greatly affects the quality of life for children and their families.

The DLQI is a key tool for measuring quality of life in dermatology.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Current methods can't accurately predict which long-form answers people prefer; evaluations should consider different answer qualities separately.

Standardized assessment tools for androgenetic alopecia are needed.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Androgenetic alopecia affects men's emotions more than symptoms or daily function.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Alopecia areata affects quality of life more in adolescents than adults.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

The new scalp coverage scoring method accurately measures hair loss and growth in men.